4,171 results on '"Neoplasms, Unknown Primary"'
Search Results
2. Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
3. Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
4. Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (CAPTIV-8)
5. TCF-001 TRACK (Target Rare Cancer Knowledge) Study (TRACK)
6. Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers (FAPI PET RDRC)
7. Sintilimab in Cancer of Unknown Primary
8. A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site (CUPISCO)
9. A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
10. Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary (OP-CUP)
11. Integrated Cancer Repository for Cancer Research (iCaRe2)
12. Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
13. HARE-40: HPV Anti-CD40 RNA vaccinE (HARE-40)
14. A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) (AGNOSTOS)
15. Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
16. Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics (VISIONARY)
17. Trial of Pembrolizumab in Cancer of Unknown Primary (CUPem)
18. Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT)
19. Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE)
20. The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
21. PaCIFiC-CUP Classifies Cancer of Unknown Primary
22. Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck (REFLECT)
23. Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP) (CUP)
24. Diagnosestellung eines „cancer of unknown primary“: Klinische Manifestationen und Lokalisationen
25. Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
26. Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (TOFFEE)
27. A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
28. FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary (FAPI-CUP)
29. Solving Riddles Through Sequencing (SIRIUS)
30. Carcinoma of Unknown Primary (CUP): A Comparison Across Tissue and Liquid Biomarkers (CUP-COMP)
31. Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
32. Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. (PUTNET)
33. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
34. APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
35. Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
36. Karzinom unklaren Ursprungs – interdisziplinäre Therapiestruktur
37. Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
38. PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
39. Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China
40. The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (PIONEER)
41. Case of metastatic epithelioid haemangioendothelioma from an unknown primary site associated with membranous nephropathy and hypercoagulable state
42. Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
43. Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
44. Nivolumab/Ipilimumab in Second Line CUP-syndrome (CheCUP)
45. Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
46. Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP (GEFCAPI04)
47. A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (RepoMeb)
48. Large neck metastasis with unknown primary tumor: A case report
49. Pancreatic herniation: a large pancreatic mass concealed within the intrathoracic cavity
50. Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.